MoonLake Immunotherapeutics
MLTX
NASDAQ
IPO2022
about MLTX
MoonLake Immunotherapeutics specializes in developing advanced immunotherapy treatments targeting a range of medical conditions.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $6.97 | $7.14 | $5.95 | $3.94B | 77.64M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.87 | n/a | n/a | 0% | 0% | 0% |